Augmented blood removal after medicinal leech feeding in congested tissue flaps
Basic science / device development published in J Rehabil Res Dev (2002)
Abstract
Reconstructive microsurgery is performed to reattach, transfer, or transplant body tissues. Venous congestion is a complication that threatens the viability of the affected tissue and is often treated with medicinal leeches. Leech therapy has two phases: active bloodletting and passive bleeding from the leech wound after detachment, which can last for several hours. Unfortunately, the small blood volumes removed by medicinal leeches are generally ineffective in decongesting tissue. Our goal was to develop a device to augment blood removal during the passive-bleeding phase of leech therapy with the use of a porcine model of venous congestion. Results indicated that the use of the device resulted in significant increases in blood retrieval relative to reports of passive bleeding alone (141%, 156%, and 155% in 1, 2, and 3 hours, respectively). These results are an encouraging first step toward development of a mechanical device that completely replaces the use of medicinal leeches in modern medicine.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Porcine model device development showing 141-156% increased blood retrieval after leech detachment versus passive bleeding alone. Step toward mechanical alternative to medicinal leeches.
Por qué esto importa para la hirudoterapia
Este estudio de evaluación probó un dispositivo mecánico diseñado para aumentar la extracción de sangre durante la fase de sangrado pasivo de la terapia con sanguijuelas, utilizando un modelo porcino de congestión venosa. El dispositivo produjo aumentos significativos en la recuperación de sangre en comparación con el sangrado pasivo solo, presentando una alternativa a las sanguijuelas medicinales en el manejo de la congestión de colgajos tisulares. Aunque esta investigación es directamente relevante para el dominio ASH al abordar una limitación conocida de la terapia con sanguijuelas—concretamente, el pequeño volumen de sangre extraído por las sanguijuelas—el objetivo último del dispositivo es reemplazar completamente el uso de sanguijuelas medicinales en la medicina moderna. Además, los resultados se basan únicamente en un modelo animal (cerdo) y carecen de validación clínica humana.
Citación
Augmented blood removal after medicinal leech feeding in congested tissue flaps.
Connor NP et al. · Journal of rehabilitation research and development, 2002
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026